Literature DB >> 23164465

HAX-1 is a nucleocytoplasmic shuttling protein with a possible role in mRNA processing.

Ewa A Grzybowska1, Valery Zayat, Ryszard Konopiński, Alicja Trębińska, Maria Szwarc, Elżbieta Sarnowska, Ewelina Macech, Jarosław Korczyński, Anna Knapp, Janusz A Siedlecki.   

Abstract

HAX-1 is a multi-functional protein that is involved in the regulation of apoptosis, cell motility and calcium homeostasis. It is also reported to bind RNA: it associates with structural motifs present in the 3' untranslated regions of at least two transcripts, but the functional significance of this binding remains unknown. Although HAX-1 has been detected in various cellular compartments, it is predominantly cytoplasmic. Our detailed localization studies of HAX-1 isoforms revealed partial nuclear localization, the extent of which depends on the protein isoform. Further studies demonstrated that HAX-1 is in fact a nucleocytoplasmic shuttling protein, dependent on the exportin 1 nuclear export receptor. Systematic mutagenesis allowed identification of the two nuclear export signals in the HAX-1 sequence. HAX-1 nuclear accumulation was observed after inhibition of nuclear export by leptomycin B, but also after specific cellular stress. The biological role of HAX-1 nuclear localization and shuttling remains to be established, but the HAX-1 transcript-binding properties suggest that it may be connected to mRNA processing and surveillance. In this study, HAX-1 status was shown to influence mRNA levels of DNA polymerase β, one of the HAX-1 mRNA targets, although this effect becomes pronounced only after specific stress is applied. Moreover, HAX-1 tethering to the reporter transcript caused a significant decrease in its expression. Additionally, the HAX-1 co-localization with P-body markers, reported here, implies a role in mRNA processing. These results suggest that HAX-1 may be involved in the regulation of expression of bound transcripts, possibly as part of the stress response.
© 2012 The Authors Journal compilation © 2012 FEBS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23164465     DOI: 10.1111/febs.12066

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  15 in total

1.  Intrinsically disordered HAX-1 regulates Ca2+ cycling by interacting with lipid membranes and the phospholamban cytoplasmic region.

Authors:  Erik K Larsen; Daniel K Weber; Songlin Wang; Tata Gopinath; Daniel J Blackwell; Michael P Dalton; Seth L Robia; Jiali Gao; Gianluigi Veglia
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-08-07       Impact factor: 3.747

2.  Gene correction of HAX1 reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cells.

Authors:  Erik Pittermann; Nico Lachmann; Glenn MacLean; Stephan Emmrich; Mania Ackermann; Gudrun Göhring; Brigitte Schlegelberger; Karl Welte; Axel Schambach; Dirk Heckl; Stuart H Orkin; Tobias Cantz; Jan-Henning Klusmann
Journal:  Blood Adv       Date:  2017-06-02

3.  Grb7 and Hax1 may colocalize partially to mitochondria in EGF-treated SKBR3 cells and their interaction can affect Caspase3 cleavage of Hax1.

Authors:  Lei Qian; Andrew M Bradford; Peter H Cooke; Barbara A Lyons
Journal:  J Mol Recognit       Date:  2016-02-12       Impact factor: 2.137

Review 4.  Long Noncoding RNAs Involved in Cardiomyocyte Apoptosis Triggered by Different Stressors.

Authors:  Jinghui Sun; Ru Wang; Tiantian Chao; Chenglong Wang
Journal:  J Cardiovasc Transl Res       Date:  2021-12-02       Impact factor: 3.216

Review 5.  Kostmann's Disease and HCLS1-Associated Protein X-1 (HAX1).

Authors:  Christoph Klein
Journal:  J Clin Immunol       Date:  2016-12-10       Impact factor: 8.317

6.  HAX-1: a novel p-body protein.

Authors:  Valery Zayat; Anna Balcerak; Jaroslaw Korczynski; Alicja Trebinska; Juliusz Wysocki; Elżbieta Sarnowska; Mateusz Chmielarczyk; Ewelina Macech; Ryszard Konopiński; Magdalena Dziembowska; Ewa A Grzybowska
Journal:  DNA Cell Biol       Date:  2015-01       Impact factor: 3.311

7.  Biased random walk model for the prioritization of drug resistance associated proteins.

Authors:  Hao Guo; Jiaqiang Dong; Sijun Hu; Xiqiang Cai; Guangbo Tang; Jianhua Dou; Miaomiao Tian; Fuchu He; Yongzhan Nie; Daiming Fan
Journal:  Sci Rep       Date:  2015-06-03       Impact factor: 4.379

8.  HAX1 regulates E3 ubiquitin ligase activity of cIAPs by promoting their dimerization.

Authors:  Jin Sun Choi; Byoung Chul Park; Seung Wook Chi; Kwang-Hee Bae; Sunhong Kim; Sayeon Cho; Woo-Chan Son; Pyung Keun Myung; Jeong-Hoon Kim; Sung Goo Park
Journal:  Oncotarget       Date:  2014-10-30

9.  HAX1 impact on collective cell migration, cell adhesion, and cell shape is linked to the regulation of actomyosin contractility.

Authors:  Anna Balcerak; Alicja Trebinska-Stryjewska; Maciej Wakula; Mateusz Chmielarczyk; Urszula Smietanka; Tymon Rubel; Ryszard Konopinski; Ewelina Macech-Klicka; Renata Zub; Ewa Anna Grzybowska
Journal:  Mol Biol Cell       Date:  2019-10-23       Impact factor: 4.138

10.  Expression and Function of HAX-1 in Human Cutaneous Squamous Cell Carcinoma.

Authors:  Xingyu Li; Tiejun Li; Bo You; Yin Shan; Si Shi; Xiaolei Cao; Li Qian
Journal:  J Cancer       Date:  2015-02-20       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.